2024 Survey on disparities in GBM treatment: toolkit
Have you or a loved one received a GBM diagnosis within the last year? (2023 and early 2024) We want to hear about your experience.
Read more
UK ranks 22nd out of 29 comparable countries for survival of Brain Cancer
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Experimental GBM treatment — DC Vax — is hoped to be moving forward in the UK
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.